- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2019–2021 · research · R21
Strengthening Patient and Caregiver Supports in Ovarian Cancer with Palliative Care: Pilot RCT of BOLSTER
Alexi A Wright · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Immune Modulation After Allogeneic HCT
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Expression and Impact of Interspersed Repeats
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · grant · PCRP
Dual Targeting of Cooperating Drivers of Prostate Cancer
Christopher Sweeney · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2024 · research · R01
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · grant · KCRP
Development and Testing of Circulating-Free Methylation DNA as a Prognostic Biomarker for Recurrent Kidney Cancer
Toni Choueiri · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2025 · career development · K00
Effects of Extracellular Mechanics on Mechanosensory and Central Neuron Function
Joy Ann Franco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface
Mikyung Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · cooperative agreement · UH2
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors
Anne Lindsay Frazier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · cooperative agreement · UH2
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors
Anne Lindsay Frazier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · research · R21
Efficient methods for identifying cryptic relatedness in millions of individuals
Alexander Gusev · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · training · T32
Cancer Chemical Biology and Metabolism Training Program
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Novel Screening Platform for Discovery of DUB Targeting Probes
Sara J Buhrlage · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · grant · KCRP
Genomic and Functional Analysis of Translocation Renal Cell Carcinoma
Srinivas Viswanathan · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2024 · research · R35
Data Analysis Tools for Emerging High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis
Carl D Novina · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Immune Modulation After Allogeneic HCT
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · career development · K08
The roles of anti-apoptotic proteins BCL-XL and MCL1 in mediating survival of high-grade serous ovarian cancer following drug-induced DNA damage
Elizabeth Harmon Stover · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · research · R21
A statistical framework to systematically characterize cancer driver mutations in noncoding genomic regions
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · research · R21
A statistical framework to systematically characterize cancer driver mutations in noncoding genomic regions
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · fellowship · F32
Elucidating the role of the SAGA complex in MYCN-amplified neuroblastoma
Clare Felicity Malone · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2020 · fellowship · Postdoctoral Fellowship
Physiological and biochemical characterization of Slit2 as mediator of adipose tissue derived thermogenesis
Christopher Riley · Dana-Farber Cancer Institute · funded by American Heart Association
2019–2024 · cooperative agreement · U24
Developing Informatics Technologies to Model Cancer Gene Regulation
Clifford Meyer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · career development · K22
Noninvasive monitoring and evaluation of anti-tumor responses as a predictive tool
Mohammad Rashidian · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · research · R01
CDK7 inhibitors as a new strategy to overcome treatment resistance in ER+ metastatic breast cancer
Rinath M. Jeselsohn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · fellowship · F32
Mismatch Repair Proteins as Drivers of Temozolomide Resistance in Glioblastoma
Adam Nathaniel Boynton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Control of PGC1alpha Translation and Function
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Genetic dissection of neural pathways that modulate systemic inflammation
Qiufu Ma · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Harold John Burstein · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · career development · K00
Effects of Extracellular Mechanics on Mechanosensory and Central Neuron Function
Joy Ann Franco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Regulators of Cancer Immunotherapy Response
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Genetic dissection of visceral pain pathways
Qiufu Ma · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Defining mechanisms of succinate regulation over adipose tissue thermogenesis
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · research · R01
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis
Carl D Novina · Dana-Farber Cancer Institute · funded by National Institutes of Health
